The Supreme Court has questioned steep markups on cancer drugs and asked the Centre to examine a uniform 16% margin on all medicines. The c...

Indian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...

While startups such as General Catalyst-backed Voy and Mumbai-based Metago are seeing higher demand from women, Elevate Now, backed by Tita...

The Kerala High Court ruled that government intervention is permissible for prohibitively priced patented medicines. The court directed the...

The United States has announced it will exempt certain speciality drugs and ingredients imported from India and 19 other countries from tar...

Novartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...

HLL Lifecare Ltd intends to broaden its pharmacy network to 600 outlets nationwide over the coming year, creating around 4,500 job opportun...

Australian PM Anthony Albanese said an OpenAI agent breached a government health website in July, accessing non-public Medicare data. Austr...

Albanese made the breach public following a telephone conversation with OpenAI chief executive Sam Altman. Both men are currently in New Yo...

The National Human Rights Commission has recommended implementing a centralised registration system for medicines in India. This system aim...

Zydus Lifesciences is transitioning from a traditional pharmaceutical company to a more patient-driven organization. The company plans to f...

"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...

Supreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a...

India’s drug regulator has warned against the indiscriminate, repeated or prolonged use of painkillers and antibiotics, citing risks includ...

HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...

Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...

India's government plans to streamline drug approval processes for domestic use. Applicants can now start studies after intimating the drug...